Curcumin,a potent anti-tumor reagent,is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation

被引:0
|
作者
Hong-li LIU~2
机构
基金
中国国家自然科学基金;
关键词
curcumin; histone deacetylase; acetylated histone H4; Raji;
D O I
暂无
中图分类号
R733.1 [网状内皮系统肿瘤];
学科分类号
100214 ;
摘要
Aim:To investigate curcumin(diferuloylmethane)induced apoptosis and its mo-lecular mechanism of action in B-NHL cell line Raji cells.Methods:Raji cells werecultured in RPMI-1640 medium and treated with curcumin in different concentra-tions.3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium(MTT)assay wasused to detect growth inhibition and Hoechst 33258 staining was used to detectapoptosis.Immunocytochemistry and Western blot were used to detect the ex-pressions of histone deacetylase 1,3,and 8(HDAC 1,HDAC3,and HDACS)andacetylated histone H4(Ac-histone H4)protein.Results:Curcumin inhibited theproliferation of B-NHL cell line Raji cells with a 36-h IC50value of 24.1±2.0μmol/L.Hoechst 33258 staining showed that curcumin could induce Raji cell apoptosis.The expression levels of HDAC1,HDAC3,and HDAC8 proteins were downregulat-ed following curcumin treatment in Raji cells,whereas Ac-histone H4 protein expres-sion was upregulated after treatment with curcumin.Conclusion:Curcumin,as anew member of the histone deacetylase inhibitors,can inhibit the expression ofclass I HDACs(HDAC1,HDAC3,and HDAC8),and can increase the expressionof Ac-histone H4 in Raji cells.Curcumin plays an important role in regulatingB-NHL cell line Raji cell proliferation and apoptosis.
引用
收藏
页码:603 / 609
页数:7
相关论文
共 50 条
  • [31] Novel histone deacetylase inhibitor N25 exerts anti-tumor effects and induces autophagy in human glioma cells by inhibiting HDAC3
    Sun, Xin-yuan
    Qu, Yue
    Ni, An-ran
    Wang, Gui-xiang
    Huang, Wei-bin
    Chen, Zhong-ping
    Lv, Zhu-fen
    Zhang, Song
    Lindsay, Holly
    Zhao, Sibo
    Li, Xiao-nan
    Feng, Bing-hong
    ONCOTARGET, 2017, 8 (43) : 75232 - 75242
  • [32] The anti-tumor effects of dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A on inducing autophagy in esophageal squamous cell carcinoma
    Wu, Ning
    Zhu, Yingfeng
    Xu, Xiao
    Zhu, Yongjun
    Song, Yang
    Pang, Liewen
    Chen, Zhiming
    JOURNAL OF CANCER, 2018, 9 (06): : 987 - 997
  • [33] Histone deacetylase 11 is an epigenetic regulator of T-cell pro-inflammatory function and novel target for enhancing T-cell anti-tumor activity
    Woods, David M.
    Sodre, Andressa L.
    Woan, Karrune
    Villagra, Alejandro
    Sarnaik, Amod
    Weber, Jeffrey
    Sotomayor, Eduardo M.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [34] Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents
    Frys, Sarah
    Simons, Zachary
    Hu, Qiang
    Barth, Matthew J.
    Gu, Juan J.
    Mavis, Cory
    Skitzki, Joseph
    Song, Liu
    Czuczman, Myron S.
    Hernandez-Ilizaliturri, Francisco J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (04) : 506 - 519
  • [35] Ibrutinib combined with low-dose histone deacetylases inhibitor chidamide synergistically enhances the anti-tumor effect in B-cell lymphoma
    Yu, Hui
    Mi, Lan
    Zhang, Weimin
    Ye, Yingying
    Li, Miaomiao
    Hu, Dingyao
    Cao, Jiaowu
    Wang, Dedao
    Wang, Xiaogan
    Ding, Ning
    Song, Yuqin
    Zhu, Jun
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 894 - 905
  • [36] A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models
    Zhang, Nannan
    Zhang, Guo
    Liu, Ning
    Lin, Wanting
    Ji, Sen
    Zheng, Mingwu
    Chen, Kai
    Liang, Xiao
    Li, Guobo
    Ma, Yu
    Zhu, Jun
    Niu, Ting
    Li, Lin-Li
    Li, Jiong
    Wei, Yu-Quan
    Yang, Sheng-Yong
    ONCOTARGET, 2017, 8 (67) : 111495 - 111507
  • [37] Expression of PD-L2, a Potent Inhibitor of Anti-Tumor Immunity, Is Characteristic of Primary Mediastinal (Thymic) Large B-Cell Lymphoma
    Shi, M.
    Sun, H. H.
    Liao, X.
    Shipp, M. A.
    Freeman, G. J.
    Rodig, S. J.
    LABORATORY INVESTIGATION, 2014, 94 : 379A - 379A
  • [38] Expression of PD-L2, a Potent Inhibitor of Anti-Tumor Immunity, Is Characteristic of Primary Mediastinal (Thymic) Large B-Cell Lymphoma
    Shi, M.
    Sun, H. H.
    Liao, X.
    Shipp, M. A.
    Freeman, G. J.
    Rodig, S. J.
    MODERN PATHOLOGY, 2014, 27 : 379A - 379A
  • [39] MLN4924, a Novel Small Molecule Inhibitor of Nedd8-Activating Enzyme, Demonstrates Potent Anti-Tumor Activity in Diffuse Large B-Cell Lymphoma
    Milhollen, Michael
    Narayanan, Usha
    Berger, Allison J.
    Thomas, Michael
    Traore, Tary
    Yu, Jie
    Zhang, Julie
    Koenig, Erik
    Garnsey, James J.
    Langston, Steven P.
    Soucy, Teresa A.
    Smith, Peter G.
    BLOOD, 2008, 112 (11) : 226 - 227
  • [40] Discovery of D-1553, a novel and selective KRas-G12C Inhibitor with potent anti-tumor activity in a broad spectrum of tumor cell lines and xenograft models.
    Shi, Zhe
    Weng, Jifang
    Fan, Xiaochong
    Wang, Emma
    Zhu, Qingqing
    Tao, Liangshan
    Han, Zixing
    Wang, Zhenwu
    Niu, Haotao
    Jiang, Yueheng
    Zhang, Ling
    Dai, Xing
    Wang, Yaolin
    CANCER RESEARCH, 2021, 81 (13)